Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Terns Pharmaceuticals Inc
TERNCurrent price
7.81 USD
+0.21 USD (+2.76%)
Last closed
7.46 USD
Company
www.ternspharma.com
ISIN
US8808811074
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
536 233 888 USD
Yield for 12 month
+39.46 %
1Y
3Y
5Y
10Y
15Y
TERN
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California. Address: 1065 East Hillsdale Boulevard, Foster City, CA, United States, 94404
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
14.21 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-881 000 USD
Last Year
-1 032 000 USD
Current Quarter
-240 000 USD
Last Quarter
-236 000 USD
Key Figures TERN
1 year
3 years
5 years
10 years
EBITDA
-107 911 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-25.99 %
PEG Ratio
–
Return On Equity TTM
-38.92 %
Wall Street Target Price
14.21 USD
Revenue TTM
1 000 000 USD
Book Value
3.11 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
1 000 000 USD
Earnings per share
-1.32 USD
Diluted Eps TTM
-1.32 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TERN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TERN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1000:50
Payout Ratio
–
Last Split Date
04.11.2013
Dividend Date
–
Stock Valuation TERN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
337.4686
Price Sales TTM
302.636
Enterprise Value EBITDA
-5.8018
Price Book MRQ
2.4521
Financials TERN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TERN
For 52 weeks
3.26 USD
10.03 USD
50 Day MA
7.72 USD
Shares Short Prior Month
2 646 584
200 Day MA
6.5 USD
Short Ratio
1.68
Shares Short
1 804 399
Short Percent
2.88 %
BeatStart